RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Alpha-9 Oncology

Alpha-9 Oncology

Alpha-9 Oncology is a clinical-stage radiopharmaceutical company that develops targeted radiotherapeutics for cancer treatment.

Latest funding

$175M Series B+ ·

Led by Lightspeed · Source: fundraisingfox.com

Funding history ↓
Website: a9oncology.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Medical, Product Research.
Stage: Series B+.
Based in: Boston, United States.
Founded: 2019.
Last round: Oct 23, 2024 · 754 days ago.
Headcount: 51–100 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredAug 24, 2023 (3 years old)
About Alpha-9 Oncology

The company creates bespoke molecules to treat cancer cells. Alpha-9 Oncology focuses on solid and hematologic malignancies.

Funding rounds

DateRoundAmountLeadSource
Series B+$175MLLightspeedfundraisingfox.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Alpha-9 Oncology

Other companies backed by Lightspeed

Lightspeed portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/alpha-9-oncology (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy